IGC Pharma (IGC) Change in Receivables (2010 - 2025)
IGC Pharma (IGC) reported Change in Receivables of -$8000.0 for Q3 2025, down 260.0% year-over-year from $5000.0 in Q3 2024, and down 300.0% quarter-over-quarter from -$2000.0 in Q1 2025.
IGC Pharma (IGC) Change in Receivables (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Change in Receivables data on file, last reported at -$8000.0 in Q3 2025.
- Change in Receivables for Q3 2025 came in at -$8000.0, down 260.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$5000.0 (up 98.36% YoY), and the FY2026 annual result was -$10000.0, down 42.86% from the prior year.
- Change in Receivables fell to -$8000.0 in Q3 2025 per IGC's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $118000.0 in Q2 2023 and troughed at -$311000.0 in Q1 2024.
- A 5-year average of -$15647.1 and a median of -$2000.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables jumped 886.67% in 2023, then slumped 627.12% in 2024.
- A 5-year view of Change in Receivables shows it stood at $25000.0 in 2021, then gained by 4.0% to $26000.0 in 2022, then plunged by 96.15% to $1000.0 in 2023, then surged by 400.0% to $5000.0 in 2024, then sank by 260.0% to -$8000.0 in 2025.
- Business Quant data shows IGC's Change in Receivables at -$8000.0 in Q3 2025, -$2000.0 in Q1 2025, and $5000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Mar 31, 2024 | -311,000.00 |
| Mar 31, 2024 | -311,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Dec 31, 2022 | 26,000.00 |